Clinical Research Directory

Inclusion Criteria: * Sign informed consent; * Between the ages of 18 and 85; * Clinical diagnosis of pulmonary hypertension, using or planning to use pulmonary hypertension targeted drugs (including any one or more of the following: prostacyclin analogues, endothelin receptor antagonists, phosphodiesterase inhibitors, soluble guanylate cyclase agonists and prostacyclin receptor agonists). Exclusion Criteria: * Have a history of mental illness or drug or poison addiction, and can not sign informed consent or can not cooperate with the experimental study; * Patients with malignant tumor and other diseases and life expectancy of less than half a year; * Short-term (less than 2 weeks) patients taking targeted drugs for pulmonary hypertension